PerkinElmer Extends Its Leadership in Drug Candidate Detection Instrumentation

PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the launch of its VICTOR™ X Multilabel Plate Reader platform at the Society for Biomolecular Sciences’ (SBS) 14th Annual Conference and Exhibition. The new VICTOR X platform will deliver to customers increased flexibility, while its enhanced versatility will enable support of new applications beyond primary screening, including quality control and therapeutic research.

The VICTOR X platform is the latest edition of PerkinElmer’s VICTOR series of best-in-class benchtop multilabel detection instruments, which are widely used by research labs of all sizes, including academic centers, pharmaceutical and biotech screening labs, drug discovery groups, and disease and therapeutic area research groups.

“Since the VICTOR platform was launched as one of the first fully-loaded multilabel plate readers on the market, PerkinElmer has remained committed to meeting customers’ demands for a range of reliable, easy-to-use and cost-effective solutions for drug discovery and research,” said Richard Eglen, PhD., president, Bio-discovery, PerkinElmer, Inc. “In developing VICTOR X we drew strongly from customer feedback, leading to an enhanced product featuring upgraded software that is customizable and open-ended for ease of integration with research applications. Our customers can now more easily create a new protocol or select and run one of several pre-set application-based protocols.”

The enhanced software package features: an improved “Start Wizard” for easier creation of new protocols; application-based example protocols for off-the-shelf use; and improved kinetics support for monitoring cellular and enzyme assays in real-time. The VICTOR X units are also designed to facilitate major accessory field upgrades, so users can add functionality as their needs evolve.